Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
The benefits of radio-chemotherapy in HIV-negative primary central nervous system (CNS) lymphomas were analyzed in 40 patients, who received radiotherapy to the brain or craniospinal axis with the total dose of 4460-5940 cGy to the primary tumor. Radiotherapy was followed by systemic chemotherapy, m...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Academy of Medical Sciences
1999
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054450/ |